The primary purpose of this study is to demonstrate the safety and effectiveness of using an intra-operative ultrasound contrast agent(Definity®) for the identification of known liver tumors.
The primary objective of this study is to demonstrate the safety of the use of intra-operative ultrasound contrast (Definity®) administration. The secondary objective of this study is to demonstrate the improved image quality and conspicuity of known liver tumors using contrast enhancement.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
6
Definity® injections given both pre-ablation and post-ablation
Norton Healthcare
Louisville, Kentucky, United States
University of Louisville Hospital
Louisville, Kentucky, United States
adverse events
Time frame: 6-weeks post surgery
identification of liver tumors
Time frame: intra-operative
improved ablation of liver tumors
Time frame: 6-weeks post surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.